Latest Articles

Publication Date
GSK gets European Commission nod for expanded use of Jemperli in endometrial cancer - Medical Dialogues

GSK gets European Commission nod for expanded use of Jemperli in endometrial cancer Medical Dialogues

Published: Jan. 21, 2025, 8 a.m.
European Commission expands Jemperli plus chemotherapy approval for endometrial cancer - Indian Pharma Post

European Commission expands Jemperli plus chemotherapy approval for endometrial cancer Indian Pharma Post

Published: Jan. 21, 2025, 4:36 a.m.
Mapping Human Uterine Disorders Through Single-Cell Transcriptomics.

Disruptions in uterine tissue function contribute to disorders such as endometriosis, adenomyosis, endometrial cancer, and fibroids, which all significantly impact health and fertility. Advances in transcriptomics, particularly single-cell RNA sequencing, …

Published: Jan. 21, 2025, midnight
Dr Vetter on the Role of Trial Inclusion Criteria on Coverage for Pembrolizumab- and Dostarlimab-Based Regimens in Endometrial Cancer - OncLive

Dr Vetter on the Role of Trial Inclusion Criteria on Coverage for Pembrolizumab- and Dostarlimab-Based Regimens in Endometrial Cancer OncLive

Published: Jan. 20, 2025, 9:34 p.m.
Dostarlimab Combo Earns Expanded European Approval in Endometrial Cancer - Cancer Network

Dostarlimab Combo Earns Expanded European Approval in Endometrial Cancer Cancer Network

Published: Jan. 20, 2025, 5:08 p.m.
GSK’s Jemperli combination approved by EC for expanded endometrial cancer use - PMLiVE

GSK’s Jemperli combination approved by EC for expanded endometrial cancer use PMLiVE

Published: Jan. 20, 2025, 12:33 p.m.
GSK’s Jemperli gains EU approval for advanced endometrial cancer treatment - DirectorsTalk Interviews

GSK’s Jemperli gains EU approval for advanced endometrial cancer treatment DirectorsTalk Interviews

Published: Jan. 20, 2025, 7:28 a.m.
GSK’s Jemperli Gains Expanded EU Approval for Broader Endometrial Cancer Treatment - TipRanks

GSK’s Jemperli Gains Expanded EU Approval for Broader Endometrial Cancer Treatment TipRanks

Published: Jan. 20, 2025, 7:19 a.m.
GSK’s Jemperli wins EU nod for broader use in front-line endometrial cancer - FirstWord Pharma

GSK’s Jemperli wins EU nod for broader use in front-line endometrial cancer FirstWord Pharma

Published: Jan. 20, 2025, 7:14 a.m.
Evaluating the association between lipidome and female reproductive diseases through comprehensive Mendelian randomization analyses.

This study aimed to assess the causal relationship between lipidome and female reproductive diseases (FRDs) using an advanced series of Mendelian randomization (MR) methods. This study utilized genome-wide association study …

Published: Jan. 19, 2025, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!